Keyphrases
Adhesion
13%
Adrenoleukodystrophy
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
8%
Bevacizumab
9%
Blood-brain Barrier
10%
Cerebral Dysfunction
12%
Cerebrospinal Fluid
11%
Classification Map
9%
Clinical Outcome Prediction
9%
Demyelination
15%
Dentate nucleus
22%
Diffusion Tensor Imaging
13%
Gadobutrol
17%
Gadolinium
12%
Gadolinium-based Contrast Agents
12%
Globus Pallidus
9%
Hematopoietic Cell Transplant
14%
Hematopoietic Cell Transplantation
9%
Hematopoietic Stem Cell Transplantation
23%
Hurler Syndrome
17%
Imaging Findings
11%
Late Gadolinium Enhancement
14%
Location-based
9%
Loes Score
9%
Lumbar Puncture
9%
Macrocyclic Gadolinium-based Contrast Agents
16%
Magnetic Resonance Imaging
17%
MRI Findings
10%
Natural History
10%
Neurocognitive
10%
Neurofibromatosis Type 1 (NF-1)
9%
Neurofibromatosis Type 2
9%
Neurological Function
10%
Neurological Outcome
9%
Nusinersen
9%
Pediatric
15%
Pediatric Patients
16%
Photosystem II
20%
Pretransplant
10%
Prevalence-based
9%
Primary Brain Tumor
9%
Psychosocial Outcomes
10%
Repeated Administration
9%
Signal Intensity Change
9%
Signal Intensity Ratio
11%
Spinal muscular Atrophy
9%
Survival Outcomes
9%
Transplantation
10%
X-linked
16%
X-linked Adrenoleukodystrophy (X-ALD)
12%
Medicine and Dentistry
Adrenoleukodystrophy
60%
Bevacizumab
6%
Biological Marker
13%
Cell Transplantation
13%
Central Nervous System
8%
Cerebellum Atrophy
5%
Cerebrospinal Fluid
10%
Computer Assisted Tomography
7%
Congenital Malformation
5%
Contrast Medium
7%
Corpus Callosum
5%
Demyelination
10%
Dentate Nucleus
7%
Diseases
15%
Embolization
9%
Epidural Space
7%
Gadobutrol
9%
Gadolinium
16%
Gray Matter
6%
Hematopoietic Cell
16%
Hematopoietic Stem Cell Transplantation
14%
Hurler Syndrome
13%
Hypoplasia
9%
Intracranial Tumor
9%
Lumbar Puncture
7%
Magnetic Resonance Imaging
53%
Magnetic Resonance Imaging
10%
Magnetic Resonance Imaging of Brain
6%
Neonatal Infant
9%
Neonates
6%
Nervous System Malformation
5%
Neurofibromatosis Type II
9%
Nusinersen
9%
Pediatrics
8%
Pediatrics Patient
10%
Posterior Fossa
6%
Prevalence
13%
Sella turcica
8%
Spinal Muscular Atrophy
9%
Vascularity
5%
